Skip to content

Compare medicines

Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.

Attribute
In shortHeart-failure pill that beats ACE inhibitors.WHO essential ACE inhibitor.
Body systemHeart & CholesterolBlood Pressure
Drug classARNIsACE inhibitors
SupplyPrescription onlyPrescription onlyWHO essential medicine
Main usesHeart failure with reduced ejection fractionHigh blood pressure, Heart failure, Diabetic kidney disease
How it worksRelaxes vessels and boosts the heart's own salt-shedding hormones.Stops the body making a hormone that tightens blood vessels.
Starts working——
Half-lifeSacubitril ~1.4 hours (active metabolite ~11 hours); valsartan ~10 hoursAbout 11 hours (enalaprilat)
Typical adult doseStart 24/26 or 49/51 mg twice a day, aiming for 97/103 mg twice a day.5–20 mg once or twice a day (maximum 40 mg a day).
FormsTablet, Pellets (children)Tablet, Oral solution, Injection (enalaprilat)
Common side effectsLow blood pressure, High potassium, Dizziness, CoughCough, Dizziness, Headache
Serious side effectsAngioedema, Kidney declineAngioedema, High potassium, Low blood pressure on first dose
Don't take if——
Alcohol——
PregnancyUsually avoidedContraindicated.Usually avoidedContraindicated in pregnancy.
Breastfeeding——
In use since20151985
Brand namesUnited States: EntrestoUnited Kingdom: EntrestoIndia: Vymada, ArnipinUnited States: Vasotec, EpanedUnited Kingdom: InnovaceIndia: Envas, Enam
Legal status——
ATC codeC09DX04C09AA02

Taken together

  • MajorSacubitril–valsartan + Enalapril: Dual blockade of the renin–angiotensin system

    Combining ACE inhibitors, ARBs or sacubitril–valsartan raises the risk of high potassium, low blood pressure and kidney injury. Sacubitril–valsartan within 36 hours of an ACE inhibitor risks dangerous swelling (angioedema).

Open in the interaction checker